What question did this study set out to answer?

The study aims to explore the clinical variations of juvenile dermatomyositis (JDM) associated with MDA5 autoantibodies.

April 24, 2026Clinical RheumatologyOpen Access

MDA5-associated juvenile dermatomyositis and interstitial lung disease from rapidly progressive to silent: a report of three cases in South African children and a review of the literature

View Full Paper

Ask AI

Bookmark

Authors

Case reports present varied clinical phenotypes in children with MDA5 autoantibodies, suggesting tailored management is vital.

The study aims to explore the clinical variations of juvenile dermatomyositis (JDM) associated with MDA5 autoantibodies.
Reported three case studies of children with juvenile dermatomyositis and interstitial lung disease.
Conducted a literature review on MDA5-associated JDM.
Analyzed the clinical phenotypes and treatment experiences.
Demonstrated significant variability in the clinical manifestations of JDM in affected children.
Highlighted the need for individualized monitoring and management strategies.
Found that the conditions can progress from severe to asymptomatic.

Lepage et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark